BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26894672)

  • 1. The cap-binding site of influenza virus protein PB2 as a drug target.
    Severin C; Rocha de Moura T; Liu Y; Li K; Zheng X; Luo M
    Acta Crystallogr D Struct Biol; 2016 Feb; 72(Pt 2):245-53. PubMed ID: 26894672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Basis of mRNA Cap Recognition by Influenza B Polymerase PB2 Subunit.
    Xie L; Wartchow C; Shia S; Uehara K; Steffek M; Warne R; Sutton J; Muiru GT; Leonard VH; Bussiere DE; Ma X
    J Biol Chem; 2016 Jan; 291(1):363-70. PubMed ID: 26559973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A molecular modelling approach to understand the effect of co-evolutionary mutations (V344M, I354L) identified in the PB2 subunit of influenza A 2009 pandemic H1N1 virus on m7GTP ligand binding.
    Bhoye D; Behera AK; Cherian SS
    J Gen Virol; 2016 Aug; 97(8):1785-1796. PubMed ID: 27154164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and functional characterization of K339T substitution identified in the PB2 subunit cap-binding pocket of influenza A virus.
    Liu Y; Qin K; Meng G; Zhang J; Zhou J; Zhao G; Luo M; Zheng X
    J Biol Chem; 2013 Apr; 288(16):11013-23. PubMed ID: 23436652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structural basis for cap binding by influenza virus polymerase subunit PB2.
    Guilligay D; Tarendeau F; Resa-Infante P; Coloma R; Crepin T; Sehr P; Lewis J; Ruigrok RW; Ortin J; Hart DJ; Cusack S
    Nat Struct Mol Biol; 2008 May; 15(5):500-6. PubMed ID: 18454157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystallization and X-ray crystallographic analysis of the cap-binding domain of influenza A virus H1N1 polymerase subunit PB2.
    Liu Y; Meng G; Luo M; Zheng X
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2013 Mar; 69(Pt 3):280-3. PubMed ID: 23519804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit.
    Dias A; Bouvier D; Crépin T; McCarthy AA; Hart DJ; Baudin F; Cusack S; Ruigrok RW
    Nature; 2009 Apr; 458(7240):914-8. PubMed ID: 19194459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the PB2 627 Domain in Influenza A Virus Polymerase Function.
    Nilsson BE; Te Velthuis AJW; Fodor E
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28122973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural analysis of specific metal chelating inhibitor binding to the endonuclease domain of influenza pH1N1 (2009) polymerase.
    Kowalinski E; Zubieta C; Wolkerstorfer A; Szolar OH; Ruigrok RW; Cusack S
    PLoS Pathog; 2012; 8(8):e1002831. PubMed ID: 22876177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bunyaviridae RNA polymerases (L-protein) have an N-terminal, influenza-like endonuclease domain, essential for viral cap-dependent transcription.
    Reguera J; Weber F; Cusack S
    PLoS Pathog; 2010 Sep; 6(9):e1001101. PubMed ID: 20862319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel small-molecule compound disrupts influenza A virus PB2 cap-binding and inhibits viral replication.
    Yuan S; Chu H; Zhang K; Ye J; Singh K; Kao RY; Chow BK; Zhou J; Zheng BJ
    J Antimicrob Chemother; 2016 Sep; 71(9):2489-97. PubMed ID: 27272726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational studies on the substrate interactions of influenza A virus PB2 subunit.
    Wang YJ; Wang JF; Ping J; Yu Y; Wang Y; Lian P; Li X; Li YX; Hao P
    PLoS One; 2012; 7(9):e44079. PubMed ID: 22957044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The crystal structure of the PB2 cap-binding domain of influenza B virus reveals a novel cap recognition mechanism.
    Liu Y; Yang Y; Fan J; He R; Luo M; Zheng X
    J Biol Chem; 2015 Apr; 290(14):9141-9. PubMed ID: 25691568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of influenza virus RNP interaction with RNA cap structures and comparison to human cap binding protein eIF4E.
    Hooker L; Sully R; Handa B; Ono N; Koyano H; Klumpp K
    Biochemistry; 2003 May; 42(20):6234-40. PubMed ID: 12755627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription and replication complex of influenza virus, a new antiviral drugs target.
    Chenavas S; Monod A; Ruigrok RWH; Crépin T
    Virologie (Montrouge); 2013 Feb; 17(1):6-16. PubMed ID: 31910551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Structural and Biochemical Analyses on the RNA-dependent RNA Polymerase of Influenza Virus for Development of Novel Anti-influenza Agents].
    Hatakeyama D
    Yakugaku Zasshi; 2017; 137(2):205-214. PubMed ID: 28154333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of the polymerase PA(C)-PB1(N) complex from an avian influenza H5N1 virus.
    He X; Zhou J; Bartlam M; Zhang R; Ma J; Lou Z; Li X; Li J; Joachimiak A; Zeng Z; Ge R; Rao Z; Liu Y
    Nature; 2008 Aug; 454(7208):1123-6. PubMed ID: 18615018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel functional site in the PB2 subunit of influenza A virus essential for acetyl-CoA interaction, RNA polymerase activity, and viral replication.
    Hatakeyama D; Shoji M; Yamayoshi S; Hirota T; Nagae M; Yanagisawa S; Nakano M; Ohmi N; Noda T; Kawaoka Y; Kuzuhara T
    J Biol Chem; 2014 Sep; 289(36):24980-94. PubMed ID: 25063805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New 7-methylguanine derivatives targeting the influenza polymerase PB2 cap-binding domain.
    Pautus S; Sehr P; Lewis J; Fortuné A; Wolkerstorfer A; Szolar O; Guilligay D; Lunardi T; Décout JL; Cusack S
    J Med Chem; 2013 Nov; 56(21):8915-30. PubMed ID: 24134208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug Design.
    Stevaert A; Naesens L
    Med Res Rev; 2016 Nov; 36(6):1127-1173. PubMed ID: 27569399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.